Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
JAK-STAT signaling in asthma
Alessandra B. Pernis, Paul B. Rothman
Alessandra B. Pernis, Paul B. Rothman
Published May 15, 2002
Citation Information: J Clin Invest. 2002;109(10):1279-1283. https://doi.org/10.1172/JCI15786.
View: Text | PDF
Perspective

JAK-STAT signaling in asthma

  • Text
  • PDF
Abstract

Authors

Alessandra B. Pernis, Paul B. Rothman

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
JAK-STAT signaling and the generation of Th1 and Th2 cells. Following an...
JAK-STAT signaling and the generation of Th1 and Th2 cells. Following antigen presentation, a naive CD4+ T cell will differentiate along the Th1 or Th2 pathway, depending on the nature of the cytokines it contacts. Signaling through the IL-12 receptor (red pathway) and its associated Jak and Stat proteins culminates in the expression of Th1-specific gene products, particularly the cytokine interferon-γ (IFN-γ) Conversely, IL-4 activates a distinct receptor complex, containing different Jaks and Stats, and favors the expression of Th2 cytokines and other gene products (black pathway). These pathways can regulate one another at the transcriptional level. In particular, the transcription factor GATA3, whose expression is induced by IL4 signaling, is essential for the transactivation of other Th2-associated genes, such as those for Th2 cytokines and chemokine receptors. Another transcription factor, T-BET, is induced by IFN-γ (and therefore indirectly by IL-12 stimulation) and also favors expression of this cytokine — thus establishing a positive feedback loop that supports Th1 polarization. In addition, T-BET silences expression of Th2-associated genes. Polarization toward the Th2 response leads to the expression of various cytokines — IL-4, IL-5, IL-6, IL-10, and IL-13 — that contribute to the pathologies seen in asthma.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts